RISK FACTORS AND MANAGEMENT OF BACTERIAL MENINGITIS

http://dx.doi.org/10.31703/giidr.2021(VI-II).04      10.31703/giidr.2021(VI-II).04      Published : Dec 2
Authored by : Mahnoor Khan , Maham Jahangir , Khadija Ahmadi

04 Pages : 24-33

References

  • Chanteau, S., Rose., A. M. C., Djibo, S., Nato, F., & Boisier, P. (2007). Biological diagnosis of meningococcal meningitis in the African meningitis belt: Current epidemic strategy and new perspective. Pascal.
  • Deghmane, A. E., Alonso, J. M., & Taha, M. K. (2009). Emerging drugs for acute bacterial meningitis. Expert opinion on emerging drugs. 14(3), pp. 381-93.
  • Stephens, D. S. (2007). Conquering the meningococcus. FEMS microbiology reviews., 31(1), pp. 3-14.
  • Umaru, E. T., Ludin, A. N. M., Majid, M. R., Sabri, S., Moses, C., Eneghuma, W., & Tajudeen A. N. (2013). Risk factors responsible for the spread of meningococal meningitis: a review. International Journal of Education and Research, 1(2), pp. 1-30.
  • Tacon, C. L., & Flower, O. (2012). Diagnosis and Management of Bacterial Meningitis in. Emergency Medicine International, p. 8.
  • Javid, M. H. (2019). Meningococcemia.
  • La Scolea, L. J., & Dryja, D. (1984). Quantitation of bacteria in cerebrospinal fluid and blood of children with meningitis and its diagnostic significance. J Clin Microbiol, Volume 19(2), pp. 187-190.
  • Griffiths, M. J., Mcgill, F., & Solomon, T. (2018). Management of acute meningitis. Clinical Medicine, 18(2), pp. 1641-69.
  • Olson MM, S. C. L. J. J. G. D. -1. 1. J., 1994 Jun. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Cen.1982- 1991ter..Infect Control Hosp Epidemiol, Volume 15(6), pp. 371-81.
  • DeLong, E. F., Stackebrandt, E., Thompson, F., Lory, S. (2013). The Prokaryotes. Human Microbiology.
  • Runde, T. J., Anjum, F., & Hafner, J. W. (2021). Bacterial Meningitis. StatPearls, Issue 2nd.
  • Scheld, W. M., Koedel, U., Nathan, B., & Pfister, H. W. (2013). Pathophysiology of Bacterial Meningitis: Mechanism(s) of Neuronal Injury. The Journal of infectious diseases. Volume 2, pp. 225-233.
  • Snape, M. D., & Pollard, A. J. (2005). Meningococcal polysaccharide-protein conjugate vaccines. Lancet Infective Diseases 5(5), pp. 21-30.
  • Stephens, D. S., Greenwood, B., & Brandtzaeg, P. (2007 Jun). Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet, Volume 369(9580), pp. 2196-2210
  • Brouwer, M. c., & Beek, D. V. D. (2013). Bacterial meningitis. In: E. R. e. al, ed. The Prokaryotes - Human Microbiology. s.l.:Springer-Verlag Berlin Heidelberg, pp. 401-427.
  • Tønjum, T., Nilsson, F., Bruun, J. N., & Haneberg, B. (january,1984). The early phase of meningococcal disease. NIPH annals. Volume 6, pp. 175-81.
  • Torpy, J. M., Lynm, c., & Glass, R. M. (2007). Meningitis. JAMA, 1(122), p. 297.

References

  • Chanteau, S., Rose., A. M. C., Djibo, S., Nato, F., & Boisier, P. (2007). Biological diagnosis of meningococcal meningitis in the African meningitis belt: Current epidemic strategy and new perspective. Pascal.
  • Deghmane, A. E., Alonso, J. M., & Taha, M. K. (2009). Emerging drugs for acute bacterial meningitis. Expert opinion on emerging drugs. 14(3), pp. 381-93.
  • Stephens, D. S. (2007). Conquering the meningococcus. FEMS microbiology reviews., 31(1), pp. 3-14.
  • Umaru, E. T., Ludin, A. N. M., Majid, M. R., Sabri, S., Moses, C., Eneghuma, W., & Tajudeen A. N. (2013). Risk factors responsible for the spread of meningococal meningitis: a review. International Journal of Education and Research, 1(2), pp. 1-30.
  • Tacon, C. L., & Flower, O. (2012). Diagnosis and Management of Bacterial Meningitis in. Emergency Medicine International, p. 8.
  • Javid, M. H. (2019). Meningococcemia.
  • La Scolea, L. J., & Dryja, D. (1984). Quantitation of bacteria in cerebrospinal fluid and blood of children with meningitis and its diagnostic significance. J Clin Microbiol, Volume 19(2), pp. 187-190.
  • Griffiths, M. J., Mcgill, F., & Solomon, T. (2018). Management of acute meningitis. Clinical Medicine, 18(2), pp. 1641-69.
  • Olson MM, S. C. L. J. J. G. D. -1. 1. J., 1994 Jun. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Cen.1982- 1991ter..Infect Control Hosp Epidemiol, Volume 15(6), pp. 371-81.
  • DeLong, E. F., Stackebrandt, E., Thompson, F., Lory, S. (2013). The Prokaryotes. Human Microbiology.
  • Runde, T. J., Anjum, F., & Hafner, J. W. (2021). Bacterial Meningitis. StatPearls, Issue 2nd.
  • Scheld, W. M., Koedel, U., Nathan, B., & Pfister, H. W. (2013). Pathophysiology of Bacterial Meningitis: Mechanism(s) of Neuronal Injury. The Journal of infectious diseases. Volume 2, pp. 225-233.
  • Snape, M. D., & Pollard, A. J. (2005). Meningococcal polysaccharide-protein conjugate vaccines. Lancet Infective Diseases 5(5), pp. 21-30.
  • Stephens, D. S., Greenwood, B., & Brandtzaeg, P. (2007 Jun). Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet, Volume 369(9580), pp. 2196-2210
  • Brouwer, M. c., & Beek, D. V. D. (2013). Bacterial meningitis. In: E. R. e. al, ed. The Prokaryotes - Human Microbiology. s.l.:Springer-Verlag Berlin Heidelberg, pp. 401-427.
  • Tønjum, T., Nilsson, F., Bruun, J. N., & Haneberg, B. (january,1984). The early phase of meningococcal disease. NIPH annals. Volume 6, pp. 175-81.
  • Torpy, J. M., Lynm, c., & Glass, R. M. (2007). Meningitis. JAMA, 1(122), p. 297.

Cite this article

APA

CHICAGO

    CHICAGO : Khan, Mahnoor, Maham Jahangir, and Khadija Ahmadi. 2021. "Risk Factors and Management of Bacterial Meningitis." Global Immunological & Infectious Diseases Review, VI (II): 24-33 doi: 10.31703/giidr.2021(VI-II).04

HARVARD

    HARVARD : KHAN, M., JAHANGIR, M. & AHMADI, K. 2021. Risk Factors and Management of Bacterial Meningitis. Global Immunological & Infectious Diseases Review, VI, 24-33.

MHRA

    MHRA : Khan, Mahnoor, Maham Jahangir, and Khadija Ahmadi. 2021. "Risk Factors and Management of Bacterial Meningitis." Global Immunological & Infectious Diseases Review, VI: 24-33

MLA

    MLA : Khan, Mahnoor, Maham Jahangir, and Khadija Ahmadi. "Risk Factors and Management of Bacterial Meningitis." Global Immunological & Infectious Diseases Review, VI.II (2021): 24-33 Print.

OXFORD

    OXFORD : Khan, Mahnoor, Jahangir, Maham, and Ahmadi, Khadija (2021), "Risk Factors and Management of Bacterial Meningitis", Global Immunological & Infectious Diseases Review, VI (II), 24-33

TURABIAN

    TURABIAN : Khan, Mahnoor, Maham Jahangir, and Khadija Ahmadi. "Risk Factors and Management of Bacterial Meningitis." Global Immunological & Infectious Diseases Review VI, no. II (2021): 24-33. https://doi.org/10.31703/giidr.2021(VI-II).04